Publications by authors named "Shuang Zhe Lin"

Claim this Profile
C
C/EBPβ-VCAM1 axis in Kupffer cells promotes hepatic inflammation in MASLD.
Shuang-Zhe Lin, Yang Xie, Yu-Qing Cheng, Rui Xue, Yin-Shi Su

JHEP Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic Landscape Analysis Reveals a Persistent DNA Damage Response in Metabolic Dysfunction-associated Steatohepatitis Post-dietary Intervention.
Zi-Yuan Zou, Tian-Yi Ren, Jia-Qi Li, Ting-Ying Jiao, Meng-Yu Wang, Shuang-Zhe Lin

J Clin Transl Hepatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causal effects from nonalcoholic fatty liver disease on cholelithiasis: A mendelian randomization study.
Yin-Shi Su, Shuang-Zhe Lin, Yuan-Wen Chen

Health Sci Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sestrin2 maintains hepatic immune homeostasis and redox balance partially via inhibiting RIPK3-mediated necroptosis in metabolic dysfunction-associated steatohepatitis.
Jian-Bin Zhang, Qian-Ren Zhang, Qian Jin, Jing Yang, Shuang-Zhe Lin

Mol Metab· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Effect of Prolyl Endopeptidase Inhibitor in High-fat Diet-induced Metabolic Dysfunction-associated Fatty Liver Disease.
Jian-Bin Zhang, Meng-Ting Li, Shuang-Zhe Lin, Yu-Qing Cheng, Jian-Gao Fan

J Clin Transl Hepatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolyl endopeptidase remodels macrophage function as a novel transcriptional coregulator and inhibits fibrosis.
Shuang-Zhe Lin, Wei-Jie Wu, Yu-Qing Cheng, Jian-Bin Zhang, Dai-Xi Jiang

Exp Mol Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral immune cells in NAFLD patients: A spyhole to disease progression.
Shuang-Zhe Lin, Jian-Gao Fan

EBioMedicine· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-alcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: Conceptual changes for clinicians, researchers and patients.
Shuang Zhe Lin, Yuan Wen Chen, Jian Gao Fan

J Dig Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolyl endopeptidase gene disruption attenuates high fat diet-induced nonalcoholic fatty liver disease in mice by improving hepatic steatosis and inflammation.
Dai-Xi Jiang, Jian-Bin Zhang, Meng-Ting Li, Shuang-Zhe Lin, Yu-Qin Wang

Ann Transl Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis